Search
UK Clinical Trial Reveals Breakthrough: New Leukemia Targeted Therapy Outperforms Chemotherapy
1 week ago /
Read about 0 minute
Author：小编
A groundbreaking study conducted by the University of Leeds in the United Kingdom has demonstrated that the combined use of targeted drugs ibrutinib and venetoclax offers significantly greater efficacy in treating chronic lymphocytic leukemia (CLL) compared to traditional chemotherapy. This novel therapy boasts an impressive 5-year progression-free survival rate of up to 93.9%, potentially heralding a new era in the treatment landscape for this prevalent form of adult leukemia.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
